Nano-X Imaging NNOX
NASDAQ NNOX
$0.38 -0.03 (-6.87%)
At close: Oct 21, 2026 · 4:00 PM EDT

Nano-X Imaging (NNOX) Current Deferred Revenue (2021 - 2026)

Updated

Nano-X Imaging (NNOX) posted Current Deferred Revenue of $601,000 for the quarter ended Jun 30, 2026, up 168.3% from $224,000 a year earlier and up 32.4% from the prior quarter.

Analysis

Nano-X Imaging (NNOX) Current Deferred Revenue (2021 - 2026) Analysis & Trends

As of Dec 31, 2025, Nano-X Imaging's Current Deferred Revenue came in at $534,000, up 281.4% from the prior year.

  • Annual Current Deferred Revenue shows a four-year compound annual growth rate of 21.3% (years ended Dec 2021 to Dec 2025).
  • In prior years, Nano-X Imaging's Current Deferred Revenue was $140,000 in the year ended Dec 31, 2024 (-74.2%), $543,000 in the year ended Dec 31, 2023 (-6.4%), $580,000 in the year ended Dec 31, 2022 (+134.8%) and $247,000 in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Current Deferred Revenue since the quarter ended Sep 30, 2022.
  • On a year-over-year basis, Current Deferred Revenue has increased in each of the last three quarters, with growth averaging 61.8% over the last eight quarters.
  • The strongest year-over-year quarter for Current Deferred Revenue in the past five years was the quarter ended Mar 31, 2026, with growth of 305.4%; the weakest was the quarter ended Sep 30, 2023, with a decline of 99.9%.
  • According to Business Quant data, Current Deferred Revenue for the three prior quarters was $454,000 (quarter ended Mar 31, 2026), $534,000 (quarter ended Dec 31, 2025) and $273,000 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Nano-X Imaging 24.96 Mn -154.71 Mn -43.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 601,000.00
Mar 31, 2026 454,000.00
Dec 31, 2025 534,000.00
Sep 30, 2025 273,000.00
Jun 30, 2025 224,000.00
Mar 31, 2025 112,000.00
Dec 31, 2024 140,000.00
Sep 30, 2024 297,000.00
Jun 30, 2024 539,000.00
Mar 31, 2024 496,000.00
Dec 31, 2023 543,000.00
Sep 30, 2023 517,000.00
Jun 30, 2023 578,000.00
Mar 31, 2023 456,000.00
Dec 31, 2022 580,000.00
Sep 30, 2022 626.00 Mn
Jun 30, 2022 298,000.00
Mar 31, 2022 283,000.00
Dec 31, 2021 247,000.00
API Access

Nano-X Imaging Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=NNOX&period=max&api_key=YOUR_API_KEY